Stock Price
2.08
Daily Change
-0.07 -3.04%
Monthly
-1.66%
Yearly
18.57%
Q2 Forecast
2.08

Mesoblast reported $2.43B in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Avita Medical AUD 105.47M 35.32M Dec/2025
Clinuvel Pharmaceuticals AUD 625.5M 105.22M Dec/2025
Cochlear AUD 17.05B 2.6B Dec/2025
CSL USD 55.89B 20.42B Dec/2025
Pacific Edge NZD 194.21M 87.84M Dec/2025
Paradigm Biopharmaceuticals AUD 145.7M 26.92M Dec/2025
PYC Therapeutics AUD 965.3M 209.97M Dec/2025
Ramsay Health Care AUD 7.93B 537.83M Dec/2025
Sonic Healthcare AUD 11.17B 1.7B Dec/2025
Telix Pharmaceuticals AUD 5.07B 5.81B Dec/2025